1. Home
  2. MRVI vs ETO Comparison

MRVI vs ETO Comparison

Compare MRVI & ETO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$3.80

Market Cap

472.8M

Sector

Health Care

ML Signal

HOLD

Logo Eaton Vance Tax-Advantage Global Dividend Opp

ETO

Eaton Vance Tax-Advantage Global Dividend Opp

HOLD

Current Price

$29.50

Market Cap

471.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRVI
ETO
Founded
2014
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
472.8M
471.2M
IPO Year
2020
2004

Fundamental Metrics

Financial Performance
Metric
MRVI
ETO
Price
$3.80
$29.50
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$4.57
N/A
AVG Volume (30 Days)
1.1M
31.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
14.29
N/A
EPS
N/A
N/A
Revenue
$185,743,000.00
N/A
Revenue This Year
$11.80
N/A
Revenue Next Year
$7.74
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.67
$20.05
52 Week High
$4.11
$31.11

Technical Indicators

Market Signals
Indicator
MRVI
ETO
Relative Strength Index (RSI) 69.37 39.87
Support Level $3.65 $27.05
Resistance Level $4.03 $29.43
Average True Range (ATR) 0.18 0.48
MACD 0.10 -0.10
Stochastic Oscillator 92.23 25.73

Price Performance

Historical Comparison
MRVI
ETO

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About ETO Eaton Vance Tax-Advantage Global Dividend Opp

Eaton Vance Tax-advtgd Global Divid Oppo is a diversified, closed-end management investment company. Its investment objective is to provide a high level of after-tax total return consisting of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. The portfolio of investments consists of capital markets, chemicals, diversified, beverages, banks, electric utilities, oil, gas and consumable fuels, personal products, and other areas.

Share on Social Networks: